Icentia Receives U.S. Food and Drug Administration (FDA) Clearance for CardioSTAT®
Legacy MEDSearch
APRIL 6, 2023
CardioSTAT has now become the leading wearable cardiac monitoring solution in Canada. The pay by duration model enables healthcare professionals to demonstrate cost savings while addressing a wide range of clinical needs. ”, said Pierre Paquet, co-founder and Chief Executive Officer at Icentia. Are you hiring?
Let's personalize your content